| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 208 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 208 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 208 |
| 3 | GEMCITABINE HYDROCHLORIDE | 174 |
| 4 | TAGRAXOFUSP | 130 |
| 5 | DEXAMETHASONE | 128 |
| 6 | DEXAMETHASONE 1.5 MG | 128 |
| 7 | GEMCITABINE | 119 |
| 8 | METHOTREXATE SODIUM | 119 |
| 9 | CYTARABINE | 112 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TAGRAXOFUSP | 130 | 0.2416 |
| 1 | DINUTUXIMAB | 33 | 0.0384 |
| 2 | ALDESLEUKIN | 42 | 0.0333 |
| 3 | CLOFARABINE | 51 | 0.0223 |
| 4 | EQUINE THYMOCYTE IMMUNE GLOBULIN | 13 | 0.0126 |
| 5 | PENTOSTATIN | 12 | 0.0114 |
| 6 | TRABECTEDIN | 25 | 0.0106 |
| 7 | CASPOFUNGIN ACETATE | 14 | 0.0088 |
| 8 | TREOSULFAN | 22 | 0.0080 |
| 9 | ALBUMIN HUMAN | 36 | 0.0072 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 311 |
| 1 | Alkylating Drug [EPC] | 287 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 213 |
| 3 | Microtubule Inhibitor [EPC] | 204 |
| 4 | Platinum-based Drug [EPC] | 151 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 148 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 137 |
| 7 | CD123 Interaction [EPC] | 130 |
| 8 | Cytotoxin [EPC] | 130 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 121 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD25-directed Cytotoxin [EPC] | 3 | 0.3000 |
| 1 | CD123 Interaction [EPC] | 130 | 0.2416 |
| 2 | Lymphocyte Growth Factor [EPC] | 42 | 0.0333 |
| 3 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 33 | 0.0304 |
| 4 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 7 | 0.0180 |
| 5 | Lymphocyte Activation Gene-3 Blocker [EPC] | 2 | 0.0039 |
| 6 | Human Blood Coagulation Factor [EPC] | 3 | 0.0036 |
| 7 | CD33-directed Immunoconjugate [EPC] | 9 | 0.0025 |
| 8 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 21 | 0.0024 |
| 9 | CD22-directed Immunoconjugate [EPC] | 7 | 0.0023 |